| abstract |
The disclosure relates to compounds of the formula (I), particularly to substituted phenyl-sulfonyl-piperazin-thieno-pyridine hydrochloride derivative compounds, wherein D, P, W, X, Y and R3 are as defined in the specification; to pharmaceutical compositions comprising these compounds, and to the use of the compounds for the prophylaxis and treatment of medical conditions relating to obesity, type II diabetes, and/or CNS disorders, to achieve reduction of body weight and of body weight gain. |